| Date Filed | Type | Description |
| 01/13/2023 |
SC 13D/A
| Quogue Capital LLC reports a 12.5% stake in Iovance Biotherapeutics, Inc. |
| 12/07/2018 |
SC 13D/A
| Quogue Capital LLC reports a 7.2% stake in Iovance Biotherapeutics, Inc. |
| 06/13/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/17/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/14/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/15/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/14/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 06/27/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/15/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 04/29/2013 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings [Amend] |
| 02/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 03/30/2012 |
SC 13G
| Quogue Capital LLC reports a 8% stake in Infinity Pharmaceuticals, Inc. |
| 02/28/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Quogue Capital LLC reports a 2.5% stake in Pharmacyclics, Inc. |
| 02/14/2011 |
SC 13G/A
| REPROS THERAPEUTICS INC. reports a 9.9% stake in Repros Therapeutics Inc. |
| 02/14/2011 |
SC 13G/A
| Talon Therapeutics, Inc. reports a 3.9% stake in Hana Biosciences, Inc. |
| 09/01/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/12/2010 |
SC 13G/A
| Talon Therapeutics, Inc. reports a 10% stake in Hana Biosciences, Inc. |
| 02/27/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/15/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |